Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
20.01. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.01.2025 | 515 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 20.01.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.01.2025ISIN NameAU000000CAI2 CALIDUS... ► Artikel lesen | |
14.01. | Nasdaq Stockholm AB: Delisting of Ziccum AB from Nasdaq First North Growth Market | 436 | GlobeNewswire | On January 10, 2025, Ziccum AB was declared bankrupt by Lund District Court.
According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the exchange may decide to delist the financial... ► Artikel lesen | |
10.01. | XFRA 7IZ: AUSSETZUNG/SUSPENSION | 371 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILZICCUM AB 7IZ SE0011415595... ► Artikel lesen | |
ZICCUM Aktie jetzt für 0€ handeln | |||||
10.01. | Ziccum AB: Ziccum AB (publ) files for bankruptcy | 323 | GlobeNewswire (Europe) | The board of directors of Ziccum AB (publ) ("Ziccum"or the "Company") has today, 10 January 2025, resolved to file for bankruptcy on behalf of the Company to manage the financial situation that has... ► Artikel lesen | |
25.11.24 | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Ziccum AB (publ) | 382 | GlobeNewswire | With effect from November 26, 2024, the unit rights in Ziccum AB (publ) will be
traded on First North Growth Market. Trading will continue up until and
including December 05, 2024.
Instrument: Unit... ► Artikel lesen | |
20.11.24 | Ziccum AB: Ziccum publishes prospectus due to upcoming rights issue | 360 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
20.11.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.11.2024 | 773 | Xetra Newsboard | Das Instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC ETF wird cum Kapitalmassnahme gehandelt am 20.11.2024 und ex Kapitalmassnahme am 21.11.2024 The instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC... ► Artikel lesen | |
29.10.24 | Ziccum AB: Ziccum AB (publ) Interim report Q3 2024 | 187 | GlobeNewswire (Europe) | INTERIM REPORT Q3, 1 JULY - 30 SEPTEMBER 2024
Significant events after Q3 2024Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loanOn October 10, The Board... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 48,060 | +0,75 % | PTA-Adhoc: PORR AG: PORR vereinbart Erwerb des österreichischen Projektentwicklungsgeschäfts und Thermenbeteiligungen von Fresenius/VAMED | DJ PTA-Adhoc: PORR AG: PORR vereinbart Erwerb des österreichischen Projektentwicklungsgeschäfts und Thermenbeteiligungen von Fresenius/VAMED
Veröffentlichung von Insiderinformationen gemäß Artikel... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,320 | +0,23 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Siemens Healthineers von 62 auf 61 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Der Medizintechnikkonzern dürfte im... ► Artikel lesen | |
THERMO FISHER | 453,85 | +0,41 % | What to Expect From Thermo Fisher's Q3 2025 Earnings Report | ||
EUROFINS SCIENTIFIC | 61,44 | -0,29 % | Eurofins Scientific SE: Weekly Report on Share Repurchases from 06th October to 10th October 2025 | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument ... ► Artikel lesen | |
SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB erweitert Investitionen in Italien mit Eröffnung eines neuen Vorzeige-Medizinzentrums in Florenz | EQS-News: SYNLAB
/ Schlagwort(e): Expansion
SYNLAB erweitert Investitionen in Italien mit Eröffnung eines neuen Vorzeige-Medizinzentrums in Florenz
09.10.2025 / 15:00 CET/CEST
Für... ► Artikel lesen | |
DAVITA | 106,30 | -0,42 % | Aktienmarkt: DaVita-Aktie tritt auf der Stelle (110,9548 €) | Wenig Kursbewegung zur Stunde bei der Aktie von DaVita . Das Wertpapier notiert derzeit bei 130,14 US-Dollar. Der Kurs der Aktie von DaVita zeigt sich aktuell kaum verändert im Vergleich zu der Schlussnotierung... ► Artikel lesen | |
DENTSPLY SIRONA | 10,380 | +1,76 % | DENTSPLY SIRONA Inc.: Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization | CHARLOTTE, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced that Aldo M. Denti has been appointed Executive Vice President... ► Artikel lesen | |
SMITH & NEPHEW | 15,455 | +1,38 % | Smith & Nephew Plc: Smith+Nephew announces new category I CPT code for its CARTIHEAL AGILI-C Cartilage Repair Implant | Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural... ► Artikel lesen | |
SONIC HEALTHCARE | 11,986 | +1,94 % | Buy, hold, sell: ResMed, Sonic Healthcare, and Steadfast | ||
DIASORIN | 74,52 | -0,90 % | DiaSorin Launches LIAISON TSH-R Ab Assay In CE Mark Countries | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI) on Friday announced the launch of its new LIAISON TSH-R Ab assay, now available in all countries recognizing the CE Mark.This test is designed to help... ► Artikel lesen | |
PATTERSON COMPANIES | 27,400 | 0,00 % | Patterson Companies Completes Acquisition by Patient Square Capital | Robert Rajalingam Appointed Chief Executive Officer and to Board of Directors
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies ("Patterson" or the "Company"), a leading supplier of products... ► Artikel lesen | |
FULGENT GENETICS | 19,000 | -2,06 % | Fulgent Genetics: A Risky Bet or a Hidden Gem? | ||
PERSPECTIVE THERAPEUTICS | 4,320 | +2,86 % | BTIG initiates coverage on Perspective Therapeutics stock with Buy rating | ||
IMPLANTICA | 5,240 | -10,27 % | Implantica completes FDA 100-Day Meeting for RefluxStop PMA application | VADUZ, Liechtenstein, Oct. 13, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative... ► Artikel lesen | |
OMNICELL | 25,400 | -1,55 % | Reasons to Add Omnicell Stock to Your Portfolio Right Now |